Get the Stockscreener App
4.02
1.62%
-0.04
Agenus Inc stock is traded at $4.02, with a volume of 288.23K.
It is down -1.62% in the last 24 hours and down -17.98% over the past month.
Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).
See More
Previous Close:
$4.06
Open:
$4.1
24h Volume:
288.23K
Relative Volume:
0.76
Market Cap:
$86.07M
Revenue:
$156.31M
Net Income/Loss:
$-245.76M
P/E Ratio:
-4.7294
EPS:
-0.85
Net Cash Flow:
$-234.16M
1W Performance:
-10.44%
1M Performance:
-17.98%
6M Performance:
-69.44%
1Y Performance:
-76.36%
1-Day Range:
$3.98
$4.12
1-Week Range:
$3.965
$4.55
52-Week Range:
$3.965
$19.69
Agenus Inc Stock (AGEN) Company Profile
Name
Agenus Inc
Sector
Industry
Phone
781-674-4410
Address
3 FORBES ROAD, LEXINGTON, MA
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-06-23 | Initiated | Robert W. Baird | Outperform |
| Feb-28-23 | Resumed | H.C. Wainwright | Buy |
| Sep-28-22 | Initiated | SMBC Nikko | Outperform |
| Dec-16-21 | Initiated | H.C. Wainwright | Buy |
| Nov-19-19 | Resumed | B. Riley FBR | Buy |
| Apr-22-19 | Initiated | B. Riley FBR | Buy |
| Oct-28-16 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Oct-27-16 | Reiterated | Maxim Group | Buy |
| Mar-11-16 | Upgrade | Maxim Group | Hold → Buy |
| Dec-16-15 | Initiated | Jefferies | Buy |
| Oct-27-15 | Downgrade | Maxim Group | Buy → Hold |
| Jul-27-15 | Reiterated | MLV & Co | Buy |
| Jun-11-15 | Initiated | Oppenheimer | Outperform |
| Jan-12-15 | Reiterated | Maxim Group | Buy |
| Jan-09-15 | Reiterated | MLV & Co | Buy |
| Jan-09-15 | Reiterated | Maxim Group | Buy |
| Dec-19-14 | Reiterated | Maxim Group | Buy |
| May-08-14 | Reiterated | Maxim Group | Buy |
| Mar-14-14 | Reiterated | MLV & Co | Buy |
| Oct-08-13 | Reiterated | Maxim Group | Buy |
| Jan-05-12 | Initiated | William Blair | Outperform |
| Dec-01-11 | Initiated | Global Hunter Securities | Buy |
View All
Agenus Inc Stock (AGEN) Latest News
AGENAgenus Inc. Latest Stock News & Market Updates - StockTitan
Agenus to Provide Third Quarter 2024 Financial Report and Corporate Update - StockTitan
Shareholders that lost money on Agenus Inc.(AGEN) should contact Levi & Korsinsky about pending Class ActionAGEN - PR Newswire
Investors in Agenus Inc. Should Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your RightsAGEN - PR Newswire
Class Action Filed Against Agenus Inc. (AGEN)November 5, 2024 Deadline to Join – Contact Levi & Korsinsky - GlobeNewswire
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Agenus Inc.(AGEN) Shareholders - PR Newswire
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus - PR Newswire
AGEN Stockholders Have Opportunity to Lead Agenus Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - AccessWire
DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors - GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agenus Inc. of Class Action Lawsuit and Upcoming DeadlinesAGEN - PR Newswire
Agenus stock hits 52-week low at $4.17 amid market challenges - Investing.com Australia
DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors of Agenus to Contact Us to Have Their Losses Evaluated Today - GlobeNewswire Inc.
Agenus stock hits 52-week low at $4.17 amid market challenges By Investing.com - Investing.com South Africa
AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Agenus Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
AGEN Investors Have Opportunity to Lead Agenus Inc. Securities F - GuruFocus.com
AGEN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Agenus Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm for More InformationAGEN - PR Newswire
Agenus Inc. Investors: Please contact the Portnoy Law Firm - GlobeNewswire
AGEN Shareholders Have Opportunity to Lead Agenus Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - AccessWire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
AGEN Investors Have Opportunity to Lead Agenus Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - AccessWire
Short Interest in Agenus Inc. (NASDAQ:AGEN) Rises By 10.6% - MarketBeat
AGEN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - AccessWire
AGENUS INC. (NASDAQ: AGEN) DEADLINE ALERT: Bernstein - GlobeNewswire
AGEN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - AccessWire
Brokerages Set Agenus Inc. (NASDAQ:AGEN) Price Target at $10.50 - MarketBeat
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus - Longview News-Journal
Class Action Lawsuit Against Agenus Inc. (NASDAQ:AGEN) - TipRanks
AGEN Investors Have Opportunity to Lead Agenus Inc. Securities Fraud Lawsuit - PR Newswire
AGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Agenus Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Allarity, Metagenomi, Agenus, and New Fortress and Encourages Investors to Contact the Firm - ForexTV.com
RLF, TOP RANKED GLOBAL COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before - The Bakersfield Californian
AGEN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
AGEN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
RLF Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AGEN - GlobeNewswire
Agenus Inc. Class Action Reminder: Robbins LLP Reminds AGEN Investors of the November 5, 2024 Lead Plaintiff Deadline in the Class Action Against Agenus Inc. - AccessWire
AQR Capital Management LLC Sells 1,173,911 Shares of Agenus Inc. (NASDAQ:AGEN) - MarketBeat
Shareholders that lost money on Agenus Inc.(AGEN) should contact The Gross Law Firm about pending Class ActionAGEN - PR Newswire
Exploring Opportunities in the Therapeutic Vaccines Market: - openPR
Agenus Inc Stock (AGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Agenus Inc Stock (AGEN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| WIINBERG ULF | Director |
Nov 15 '23 |
Buy |
0.76 |
25,000 |
19,000 |
124,063 |
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):